The platelet aggregation devices market size has grown exponentially in recent years. It will grow from $0.67 billion in 2023 to $0.83 billion in 2024 at a compound annual growth rate (CAGR) of 25.3%. The growth observed during the historic period can be attributed to several factors, including the increasing prevalence of cardiovascular diseases, rising incidences of bleeding disorders, growing awareness about the importance of health diagnostics, an increase in surgical procedures requiring accurate diagnostics, and advancements leading to improved diagnostic accuracy in healthcare settings.
The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 25.5%. The anticipated growth in the forecast period can be attributed to several factors, including the growing aging population leading to higher healthcare needs, a rising demand for point-of-care testing for convenient and rapid diagnostics, the expansion of personalized medicine approaches tailoring treatments to individual patients, regulatory support and approvals facilitating innovation in healthcare technologies, and the increasing prevalence of chronic diseases requiring effective diagnostics and management. Major trends expected in the forecast period include the integration of artificial intelligence (AI) in diagnostics to enhance accuracy and efficiency, the development of portable platelet aggregation devices for convenient and on-the-go testing, increased collaboration between biotech firms and healthcare providers to drive innovation, the rising importance of data analytics in healthcare for informed decision-making, and a shift towards home-based diagnostics for patient convenience and remote monitoring capabilities.
The platelet aggregation devices market is poised for growth, driven by the increasing prevalence of target diseases, which are significant medical conditions that require focused prevention, diagnosis, and treatment efforts, such as cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices play a crucial role in reducing the incidence of target diseases by facilitating early detection and effective management of thrombotic risks, thereby preventing complications such as heart attacks and strokes in vulnerable populations. For example, as of February 2024, the International Agency for Research on Cancer (IARC) reported approximately 20 million new cancer cases and 9.7 million deaths globally in 2022, with projections indicating a substantial increase in new cases by 2050. This rise in target diseases is a key driver for the platelet aggregation devices market.
Leading companies in the platelet aggregation devices sector are intensifying their efforts to develop advanced solutions by introducing innovative products such as the first platelet pooling set designed to stabilize the U.S. platelet supply and address growing demands. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC. announced the FDA approval of the IMUGARD WB Platelet Pooling Set, offering extended shelf life, seven-day storage clearance, and enabling platelet recoupment from whole blood donations. This advancement improves platelet availability, supply management efficiency, and supports critical medical procedures such as chemotherapy and organ transplants.
In August 2023, Cell Microsystems acquired Fluxion Biosciences Inc., expanding the platelet aggregation devices market with advanced systems such as IonFlux, BioFlux, and IsoFlux, integrating automated patch clamp technology for cellular electrophysiology, and providing tools for live cell assays and platelet aggregation studies. Fluxion Biosciences Inc. specializes in automating complex assays, including platelet aggregation and thrombus formation, further enhancing the market's capabilities.
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago.
North America was the largest region in the platelet aggregation devices market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the platelet aggregation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Platelet aggregation devices are specialized tools utilized to measure the rate and extent of platelet clumping, a critical aspect in diagnosing and managing blood clotting disorders. These devices play a key role in evaluating the efficacy of antiplatelet therapies, diagnosing bleeding disorders, and assessing platelet function across various clinical and research environments.
The primary types of platelet aggregation devices include reagents, systems, consumables, and accessories. Reagents are substances employed in laboratory experiments to induce platelet aggregation, aiding in the diagnosis of blood clotting disorders. Each reagent serves a specific function, contributing to precise analysis and treatment planning. These devices may feature different channel configurations such as four channels, dual channels, or eight channels, and utilize technologies such as optical, impedance, and others. They find application in clinical settings, research endeavors, cardiovascular assessments, orthopedic evaluations, and more. End users of these devices include standalone hospitals, diagnostic laboratories, research and academic institutes, and other relevant entities.
The platelet aggregation devices market research report is one of a series of new reports that provides platelet aggregation devices market statistics, including platelet aggregation devices industry global market size, regional shares, competitors with a platelet aggregation devices market share, detailed platelet aggregation devices market segments, market trends and opportunities, and any further data you may need to thrive in the platelet aggregation devices industry. This platelet aggregation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The platelet aggregation devices market consists of revenues earned by entities by providing services such as calibration and maintenance services, device training and education programs, data management and analysis services, remote monitoring and technical support, customization and integration services, and regulatory compliance consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The platelet aggregation devices market also includes sales of products such as laser-based aggregometers, microfluidic devices, biosensor-based aggregation analyzers, point-of-care platelet function analyzers, fluorescence-based aggregation systems, and nanotechnology-enhanced platelet testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 25.5%. The anticipated growth in the forecast period can be attributed to several factors, including the growing aging population leading to higher healthcare needs, a rising demand for point-of-care testing for convenient and rapid diagnostics, the expansion of personalized medicine approaches tailoring treatments to individual patients, regulatory support and approvals facilitating innovation in healthcare technologies, and the increasing prevalence of chronic diseases requiring effective diagnostics and management. Major trends expected in the forecast period include the integration of artificial intelligence (AI) in diagnostics to enhance accuracy and efficiency, the development of portable platelet aggregation devices for convenient and on-the-go testing, increased collaboration between biotech firms and healthcare providers to drive innovation, the rising importance of data analytics in healthcare for informed decision-making, and a shift towards home-based diagnostics for patient convenience and remote monitoring capabilities.
The platelet aggregation devices market is poised for growth, driven by the increasing prevalence of target diseases, which are significant medical conditions that require focused prevention, diagnosis, and treatment efforts, such as cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices play a crucial role in reducing the incidence of target diseases by facilitating early detection and effective management of thrombotic risks, thereby preventing complications such as heart attacks and strokes in vulnerable populations. For example, as of February 2024, the International Agency for Research on Cancer (IARC) reported approximately 20 million new cancer cases and 9.7 million deaths globally in 2022, with projections indicating a substantial increase in new cases by 2050. This rise in target diseases is a key driver for the platelet aggregation devices market.
Leading companies in the platelet aggregation devices sector are intensifying their efforts to develop advanced solutions by introducing innovative products such as the first platelet pooling set designed to stabilize the U.S. platelet supply and address growing demands. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC. announced the FDA approval of the IMUGARD WB Platelet Pooling Set, offering extended shelf life, seven-day storage clearance, and enabling platelet recoupment from whole blood donations. This advancement improves platelet availability, supply management efficiency, and supports critical medical procedures such as chemotherapy and organ transplants.
In August 2023, Cell Microsystems acquired Fluxion Biosciences Inc., expanding the platelet aggregation devices market with advanced systems such as IonFlux, BioFlux, and IsoFlux, integrating automated patch clamp technology for cellular electrophysiology, and providing tools for live cell assays and platelet aggregation studies. Fluxion Biosciences Inc. specializes in automating complex assays, including platelet aggregation and thrombus formation, further enhancing the market's capabilities.
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago.
North America was the largest region in the platelet aggregation devices market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the platelet aggregation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Platelet aggregation devices are specialized tools utilized to measure the rate and extent of platelet clumping, a critical aspect in diagnosing and managing blood clotting disorders. These devices play a key role in evaluating the efficacy of antiplatelet therapies, diagnosing bleeding disorders, and assessing platelet function across various clinical and research environments.
The primary types of platelet aggregation devices include reagents, systems, consumables, and accessories. Reagents are substances employed in laboratory experiments to induce platelet aggregation, aiding in the diagnosis of blood clotting disorders. Each reagent serves a specific function, contributing to precise analysis and treatment planning. These devices may feature different channel configurations such as four channels, dual channels, or eight channels, and utilize technologies such as optical, impedance, and others. They find application in clinical settings, research endeavors, cardiovascular assessments, orthopedic evaluations, and more. End users of these devices include standalone hospitals, diagnostic laboratories, research and academic institutes, and other relevant entities.
The platelet aggregation devices market research report is one of a series of new reports that provides platelet aggregation devices market statistics, including platelet aggregation devices industry global market size, regional shares, competitors with a platelet aggregation devices market share, detailed platelet aggregation devices market segments, market trends and opportunities, and any further data you may need to thrive in the platelet aggregation devices industry. This platelet aggregation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The platelet aggregation devices market consists of revenues earned by entities by providing services such as calibration and maintenance services, device training and education programs, data management and analysis services, remote monitoring and technical support, customization and integration services, and regulatory compliance consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The platelet aggregation devices market also includes sales of products such as laser-based aggregometers, microfluidic devices, biosensor-based aggregation analyzers, point-of-care platelet function analyzers, fluorescence-based aggregation systems, and nanotechnology-enhanced platelet testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Platelet Aggregation Devices Market Characteristics3. Platelet Aggregation Devices Market Trends And Strategies32. Global Platelet Aggregation Devices Market Competitive Benchmarking33. Global Platelet Aggregation Devices Market Competitive Dashboard34. Key Mergers And Acquisitions In The Platelet Aggregation Devices Market
4. Platelet Aggregation Devices Market - Macro Economic Scenario
5. Global Platelet Aggregation Devices Market Size and Growth
6. Platelet Aggregation Devices Market Segmentation
7. Platelet Aggregation Devices Market Regional And Country Analysis
8. Asia-Pacific Platelet Aggregation Devices Market
9. China Platelet Aggregation Devices Market
10. India Platelet Aggregation Devices Market
11. Japan Platelet Aggregation Devices Market
12. Australia Platelet Aggregation Devices Market
13. Indonesia Platelet Aggregation Devices Market
14. South Korea Platelet Aggregation Devices Market
15. Western Europe Platelet Aggregation Devices Market
16. UK Platelet Aggregation Devices Market
17. Germany Platelet Aggregation Devices Market
18. France Platelet Aggregation Devices Market
19. Italy Platelet Aggregation Devices Market
20. Spain Platelet Aggregation Devices Market
21. Eastern Europe Platelet Aggregation Devices Market
22. Russia Platelet Aggregation Devices Market
23. North America Platelet Aggregation Devices Market
24. USA Platelet Aggregation Devices Market
25. Canada Platelet Aggregation Devices Market
26. South America Platelet Aggregation Devices Market
27. Brazil Platelet Aggregation Devices Market
28. Middle East Platelet Aggregation Devices Market
29. Africa Platelet Aggregation Devices Market
30. Platelet Aggregation Devices Market Competitive Landscape And Company Profiles
31. Platelet Aggregation Devices Market Other Major And Innovative Companies
35. Platelet Aggregation Devices Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Platelet Aggregation Devices Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on platelet aggregation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for platelet aggregation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The platelet aggregation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Reagents; Systems; Consumables And Accessories2) By Type: Four Channel; Dual Channel; Eight Channel
3) By Technology: Optical; Impedance; Other Technologies
4) By Application: Clinical Applications; Research Applications; Cardiovascular Applications; Orthopedic Applications; Other Applications
5) By End-User: Standalone Hospitals; Diagnostic Laboratories; Research And Academic Institutes; Other End Users
Key Companies Mentioned: Roche Holding AG; Cytiva (Danaher Corp.); Siemens Healthineers; Sysmex Corporation; WerfenLife S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Roche Holding AG
- Cytiva (Danaher Corp.)
- Siemens Healthineers
- Sysmex Corporation
- WerfenLife S.A.
- Haemonetics Corporation
- Helena Laboratories Corporation
- Sarstedt AG & Co. KG
- Sekisui Diagnostics LLC
- Diagnostica Stago
- Accriva Diagnostics Holdings Inc.
- Drucker Diagnostics
- Sentinel CH. SpA
- ADInstruments
- Chrono-Log Corporation
- Bio/Data Corporation
- Haemochrom Diagnostica GmbH
- AggreDyne Inc.
- Hart Biologicals Ltd.
- Stago
Methodology
LOADING...